Mineralys Therapeutics, Inc.
Industry: Life Sciences ・ $MLYS on Nasdaq
Insider Sale
+$145,972
-4.34%
Shares
Shares Volume: 10,757 Shares
Average Share Price: $13.57
INSIDER
Levy Adam Scott
CFO and Secretary (Officer)
reported on Oct 15 2024
traded on Oct 11 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 236,854 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $513,368.52 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 10 |
| P/S VALUE RATIO | 0.706 |
| AVERAGE SALE VALUE | $1,065,709.7 |
| COMPANY PREVIOUS TRADES |